Management of checkpoint inhibitor toxicity and survival in patients with advanced melanoma.

被引：0
|
作者：
van Not, Olivier Jules
Verheijden, Rik Jasper
van den Eertwegh, Alfonsus Johannes Maria
Haanen, John B. A. G.
Blank, Christian U.
Aarts, Maureen J. B.
Van den Berkmortel, Franchette
de Groot, Jan Willem
Hospers, Geke
Kapiteijn, Ellen
de Meza, Melissa Melanie
Piersma, Djura
Van Rijn, Rozemarijn
Stevense-den Boer, Marion
Van Der Veldt, Astrid Aplonia Maria
Vreugdenhil, Gerard
Boers-Sonderen, Marye J.
Blokx, Willeke
Wouters, Michel W. J. M.
Suijkerbuijk, Karijn
机构：
[1] Univ Med Ctr Utrecht, Leiden, Netherlands
[2] Univ Medisch Cent Utrecht, Utrecht, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[4] Antoni Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Maastricht Univ Med Ctr, Maastricht, Netherlands
[7] Zuyderland Med Ctr Sittard, Dept Med Oncol, Sittard, Netherlands
[8] Isala Oncol Ctr, Dept Med Oncol, Zwolle, Netherlands
[9] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
[10] Leiden Univ Med Ctr, Dept Med Oncol, Leiden, Netherlands
[11] Leiden Univ Med Ctr, Leiden, Netherlands
[12] MST, Enschede, Netherlands
[13] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[14] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[15] Erasmus MC, Dept Med Oncol & Radiol Nucl Med, Rotterdam, Netherlands
[16] Maxima Med Ctr, Eindhoven, Netherlands
[17] Radboudumc, Nijmegen, Netherlands
[18] UMC Utrecht, Utrecht, Netherlands
[19] Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9546
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The effect of the microbiome on immune checkpoint inhibitor toxicity in patients with melanoma.
    Williams, Nyelia
    Hoyd, Rebecca
    Wheeler, Caroline E.
    Lynn, Mari
    Bibi, Amna
    Gray, Shannon
    Bodner, Michael
    Arya, Namrata
    Roberts, Scott
    Hoang, Phuong
    Apparicio, Jessica
    Merrill, Deanna
    Wu, Richard Cheng Han
    Verschraegen, Claire F.
    Burd, Christin Elizabeth
    Kendra, Kari Lynn
    Spakowicz, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Salvage combination ipilimumab and nivolumab after failure of prior checkpoint inhibitor therapy in patients with advanced melanoma.
    Gaughan, Elizabeth Mary
    Petroni, Gina R.
    Grosh, William W.
    Slingluff, Craig L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Efficacy of checkpoint inhibition in advanced acral melanoma.
    de Meza, Melissa Melanie
    van Not, Olivier Jules
    Blokx, Willeke
    Bonenkamp, Han J.
    Blank, Christian U.
    van den Eertwegh, Alfonsus Johannes Maria
    Aarts, Maureen J. B.
    Stevense, Marion
    van den Berkmortel, Franchette
    Boers-Sonderen, Marye
    de Groot, Jan Willem
    Haanen, John B. A. G.
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Suijkerbuijk, Karijn
    Wouters, Michel W. J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Evaluation of the clinical benefits of immune checkpoint inhibitors in patients with advanced melanoma.
    Ou, Qiyun
    Yu, Yunfang
    Lin, Dagui
    Fu, Tuping
    Gao, Quanlong
    Luo, Baoming
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [5] Frailty and checkpoint inhibitor toxicity in older patients with melanoma
    Bruijnen, Cheryl P.
    Koldenhof, Jose J.
    Verheijden, Rik J.
    van den Bos, Frederiek
    Emmelot-Vonk, Marielle H.
    Witteveen, Petronella O.
    Suijkerbuijk, Karijn P. M.
    CANCER, 2022, 128 (14) : 2746 - 2752
  • [6] Survival of Mucosal Melanoma Patients in the Immune Checkpoint Inhibitor Era
    Hsu, Charles
    Xing, Jessica
    Stea, Baldassarre
    Dougherty, Shona
    Shaheen, Montaser
    Christopher, Le
    Robbins, Jared
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (10): : S90 - S91
  • [7] Elective Discontinuation of Checkpoint Inhibitor Therapy in Patients with advanced Melanoma
    Persa, O. D.
    Schatton, K.
    Ruebben, A.
    Berking, C.
    Erdmann, M.
    Schlaak, M.
    Mauch, C.
    Steeb, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 40 - 40
  • [8] REPRODUCTIVE IMPACT OF IMMUNE CHECKPOINT INHIBITOR THERAPY IN WOMEN WITH MELANOMA.
    Rhodes, Quinn
    Woodard, Terri L.
    Roth, Michael
    Detti, Laura
    Shott, Susan
    McKenzie, Laurie
    FERTILITY AND STERILITY, 2024, 122 (04) : E307 - E307
  • [9] A prediction model for response to immune checkpoint inhibition in advanced melanoma.
    van Duin, Isabella A. J.
    Verheijden, Rik Jasper
    van Diest, Paul J.
    van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Haanen, John B. A. G.
    Hospers, Geke
    Piersma, Djura
    van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Stevense-den Boer, Marion
    Boers-Sonderen, Marye J.
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Elias, Sjoerd G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Treatment beyond progression with immune checkpoint inhibitors in advanced melanoma.
    Sobczuk, Pawel
    Czarnecka, Anna Malgorzata
    Spalek, Mateusz
    Teterycz, Pawel
    Dudzisz-Sledz, Monika
    Switaj, Tomasz
    Rogala, Pawel
    Placzke, Joanna
    Kozak, Katarzyna
    Borkowska, Aneta
    Kosela-Paterczyk, Hanna
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345